Clinical study of gatiflixacin on male non-gonococcal urethritis

Clinical study of gatiflixacin on male non-gonococcal urethritis - GONG study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004542

Enrollment

300

Registered

2010-11-11

Start date

2008-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-gonococcal urethritis

Interventions

Gatifloxacin with 200mg is administrated twice a day for 7 days

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male patient with non-gonococcal urethritis

Exclusion criteria

Exclusion criteria: Patients with gonococcal urethritis Patients who have sexual intercourse without using condom

Design outcomes

Primary

Measure	Time frame
To evaluate the microbiological efficacies of gatifloxacin against microorganisms of non-gonococcal urethritis To examine the antimicrobial susceptibilitities of Mycoplasma genitalium to fluoroquinolones	—

Secondary

Measure	Time frame
To evaluate the clinical efficacies of gatifloxacin to non-gonococcal urethritis	—

Countries

Japan

Contacts

Public ContactRyoichi Hamasuna

University of Occupational and Environmental Health Department of Urology

hamaryo@med.uoeh-u.ac.jp093-691-7446

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026